Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00082836
Status:
COMPLETED
Last Update Posted:
2013-01-17
First Post:
2004-05-14
Brief Title:
Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent Primary CNS Lymphoma
Sponsor:
Organization:
Memorial Sloan Kettering Cancer Center